Case Discussion: DMD

The France Foundation

C. Proud, A. Veerapandiyan, C. Mcdonald

DMD Management in the Era of Gene Therapy

The France Foundation

A. Veerapandiyan, C. Zaidman

Impact of Combination Therapies and Exercise Programs for Neuromuscu…

The France Foundation

A. Veerapandiyan, J. Brandsema, L. Servais

Duchenne Muscular Dystrophy and Gene Therapy: What's On the Horizon?

The France Foundation

H. Abdel-Hamid, A. Veerapandiyan

Emerging Therapies for Neuromuscular Diseases in 2021: ALS, Dystroph…

Houston Methodist

E. Greene

Approach to a Child with Delayed Walking

UCSF School of Medicine

Y. Mitsuya

Updates in Myotonic Dystrophy

Muscular Dystrophy Association

S. Shroff

The Technology Will See You Now: Digital Endpoints and AI Applicatio…

Henry J. Kaminski

Principles of AAV Gene Therapy for Inherited Neurological Disorders:…

American Neurological Association

S. G. Kaler, B. Traynor

Non-Dystrophin Muscular Dystrophies: Gene Variants & Clinical Featur…

ZINCARE

D. Leung

Newborn Screening for Duchenne Muscular Dystrophy

United Scientific Group

R. Rodney Howell

Functional Biomarkers for Muscular Dystrophy

The France Foundation

J. Brandsema, L. Servais, A. Veerapandiyan

Advanced Imaging in Neurological Diseases: Mind the Gap

University at Buffalo Neurology Department

N. Bergsland

Clinical Updates in DMD

The France Foundation

J. Brandsema, A. Veerapandiyan, L. Servais

Introduction to Dystrophin

The France Foundation

C. Mcdonald

Therapies for DMD

The France Foundation

C. Mcdonald

Cell-Based Therapies for Neuromuscular Diseases

Houston Methodist

B. Liao

Facioscapulohumeral Muscular Dystrophy

Vineeth Jaison

S. S Nair, U. Kalane

Pediatric Neuromuscular Disorders

ZINCARE

J. Wilmshurst

Heterogeneity in Muscular Dystrophies

The France Foundation

L. Servais, J. Brandsema